DEPOTSYSTEME MIT GLATIRAMERACETAT

European patent · EP4252849 · In force

Register entry

Publication number
EP4252849
Application number
EP23173177
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 9, 2017
Published
Oct 4, 2023
Granted
Feb 19, 2025
Protection ends at the latest
Aug 8, 2037
Next annual fee due
Aug 31, 2026
IPC classes
A61K 38/02 (2006.01)
A61K 38/10 (2006.01)
A61K 38/16 (2006.01)
A61K 9/00 (2006.01)
A61K 9/16 (2006.01)
A61K 9/50 (2006.01)
A61K 47/32 (2006.01)
A61K 47/36 (2006.01)
A61P 25/00 (2006.01)
A61P 25/28 (2006.01)
Priority
US 201662381598 P 31.08.2016
Divided from
EP17845658
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 31, 2025

    Change

    Published in Swissreg on 31.12.2025

  2. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  3. Mar 31, 2025

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 31.03.2025

  4. Feb 19, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.02.2025

Parties

Holder

Mapi Pharma Ltd.

16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, IL

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

BLEICH KIMELMAN, Nadav

6941617 Tel Aviv, IL

RUBNOV, Shai

6581141 Tel Aviv, IL

MAROM, Ehud

6713317 Tel Aviv, IL

DANON, Uri

6935978 Tel Aviv, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.